Abstract
This study aimed to examine the current situation of anti-cancer drug shortages in Pakistan, namely its determinants, impacts, adopted mitigation strategies, and proposed solutions. Qualitative semi-structured, in-depth interviews were conducted with 25 pharmacists in oncology hospitals in Pakistan from August to October 2021. Data were collected in person and online, recorded, and subjected to inductive thematic analysis after being transcribed verbatim. Most participants experienced anti-cancer drug shortages that increased during the pandemic. Etoposide, paclitaxel, vincristine, dacarbazine, and methotrexate were frequently short. Important causes included the compromised role of regulatory authorities, lack of local production, and inventory mismanagement. The impacts were delayed/suboptimal treatment and out-of-pocket costs for patients, patients’ prioritization, increased workload, negative work environment, and patients’ trust issues for pharmacists. The participants proposed that a cautious regulator’s role is needed to revise policies for all stakeholders and support all stakeholders financially at their level to increase access to these medicines. Based on the outcomes, it is clear that anti-cancer medicine shortages are a current issue in Pakistan. Governmental authorities need to play a role in revising policies for all levels of the drug supply chain and promoting local production of these drugs. Stakeholders should also collaborate and manage inventory.
Funder
National Natural Science Foundation of China
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference38 articles.
1. Vogler, S., Paris, V., and Panteli, D. (2018). Ensuring Access to Medicines: How to Redesign Pricing, Reimbursement and Procurement?, World Health Organization, Regional Office for Europe.
2. Therapeutic drug monitoring of cancer chemotherapy;Alnaim;J. Oncol. Pharm. Pract.,2007
3. Impact of Oncology Drug Shortages on Chemotherapy Treatment;Alpert;Clin. Pharmacol. Ther.,2019
4. Oncology Drug Shortages—What We Have Versus What We Expect to Have? A Critical Scenario of Pakistan;Elahi;J. Pharm. Technol.,2018
5. Oncology drug shortages in the USA—Business as usual;Fox;Nat. Rev. Clin. Oncol.,2020
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献